CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Net revenue	$ 35,851	$ 30,268	$ 104,689	$ 75,924
Cost of goods sold	7,096	7,049	20,209	15,386
Gross Profit	28,755	23,219	84,480	60,538
Operating expenses
Research and development costs	4,118	2,346	11,254	8,174
Selling, general, and administrative	28,968	16,958	79,009	50,962
Total operating expenses	33,086	19,304	90,263	59,136
Operating (loss) income	(4,331)	3,915	(5,783)	1,402
Other expense
Other expense	(98)	(56)	(124)	(141)
Interest expense	(573)	(70)	(1,174)	(532)
Total other expense	(671)	(126)	(1,298)	(673)
(Loss) income before income taxes	(5,002)	3,789	(7,081)	(729)
Income tax expense (benefit)	105	(19)	437	1,396
Net (loss) income	(5,107)	3,808	(7,518)	(667)
Less: cumulative dividends on Series B convertible preferred stock	(574)	(333)	(1,516)	(333)
Net (loss) income attributable to common stockholders	(5,681)	3,475	(9,034)	(1,000)
Foreign currency translation adjustment	(121)	366	(575)	(76)
Comprehensive (loss) income	$ (5,802)	$ 3,841	$ (9,609)	$ (1,076)
Weighted average number of common stocks outstanding:
Basic	47,005,334	43,429,308	46,926,344	42,792,176
Diluted	47,005,334	61,376,701	46,926,344	42,792,176
Net (loss) income per share attributable to common stockholders:
Basic	$ (0.12)	$ 0.08	$ (0.19)	$ (0.02)
Diluted	$ (0.12)	$ 0.06	$ (0.19)	$ (0.02)